Exhibit 99.1
 
MAXIMUS Reports Fourth Quarter and Full Year Financial Results for Fiscal 2014
 
RESTON, Va.--(BUSINESS WIRE)--November 13, 2014--MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, today reported financial results for its fourth quarter and fiscal year ended September 30, 2014.
 
Highlights for the fourth quarter and the full fiscal year 2014 include:
 
●  
Fourth quarter revenue grew 13% to $435.4 million; diluted earnings per share increased 4% to $0.53.
 
●  
Fiscal year 2014 revenue grew 28% to $1.7 billion; diluted earnings per share totaled $2.11.
 
●  
Cash and cash equivalents totaled $158.1 million at September 30, 2014.
 
●  
Backlog totaled $3.8 billion at September 30, 2014 compared to $3.4 billion at September 30, 2013.
 
●  
Signed contract awards totaled $2.0 billion for fiscal 2014 and the sales pipeline remained strong at $3.5 billion at September 30, 2014.
 
For the fourth quarter of fiscal 2014, revenue increased 13% to $435.4 million compared to revenue of $384.3 million reported for the same period last year, driven by growth in the Health Services Segment. Fiscal 2014 fourth quarter net income attributable to MAXIMUS totaled $36.2 million, or $0.53 per diluted share. This represents a 4% increase compared to $0.51 reported for the same period last year.
 
Revenue for fiscal year 2014 increased 28% to $1.7 billion. This compares to $1.3 billion reported for fiscal 2013, which included approximately $16.0 million in revenue from a terminated contract in the Human Services Segment. Excluding revenue from the terminated contract, fiscal 2014 revenue grew 29%, of which 27% was organic. Revenue increases for the fiscal year were driven by the Health Services Segment and included work tied to the Affordable Care Act and the Health Management acquisition.
 
For the full fiscal year, net income attributable to MAXIMUS totaled $145.4 million, or $2.11 per diluted share. This compares to $116.7 million, or $1.67 per diluted share, for the same period last year. The prior-year period included a benefit of $10.9 million in pre-tax income ($6.5 million, net of taxes, or $0.09 per diluted share) related to the aforementioned terminated contract. Excluding the terminated contract, fiscal 2014 diluted earnings per share increased 34% to $2.11 compared to adjusted diluted earnings per share of $1.58 reported for fiscal 2013. The year-over-year increase in earnings for the full fiscal year is principally attributable to growth in the Health Services Segment. A reconciliation to non-GAAP measures is included in the accompanying financial schedules.
 
Fiscal 2014 has been a year of exceptional growth for MAXIMUS, highlighted by solid execution and strong financial results. Year-to-date signed awards reached a record $2.0 billion and contributed to a healthy backlog of $3.8 billion. The Company has made significant progress on our long-term objectives of expanding our operations outside of the United States, as well as continuing to grow our U.S. domestic business, which includes our work serving federal agencies and programs. With a clear demonstrated success that is built upon our ‘land and expand’ strategy over the last several years, we have broadened our reach into new markets, new adjacencies and new clients,” commented Richard A. Montoni, MAXIMUS Chief Executive Officer.
 
 
 
 
 
Health Services Segment
 
Health Services Segment revenue for the fourth quarter of fiscal 2014 increased 19% to $321.7 million compared to the same period last year. As expected, Health Services Segment operating income for the fourth quarter of fiscal 2014 decreased 7% to $42.8 million (13.3% operating margin) compared to $45.9 million (16.9% operating margin) for the same period last year.
 
For the full fiscal year, Health Services Segment revenue increased 45% to $1.25 billion compared to the same period last year. For fiscal 2014, Health Services Segment operating income increased 35% to $175.4 million (14.0% operating margin) compared to $129.8 million (15.0% operating margin) for fiscal 2013.
 
For both the fourth quarter and the full year of fiscal 2014, increases to revenue were driven by new work, including contracts supporting the Affordable Care Act in the United States, and expansion on existing programs. During fiscal 2014, the Company also received a full-year’s benefit from the Health Management acquisition, which closed on July 1, 2013. As expected, operating margins for both the fourth quarter and the full fiscal year were lower due to an increase in lower-margin, cost-reimbursable contracts, as well as the expected start-up from new programs that launched in 2014.
 
Human Services Segment
 
Human Services Segment revenue for the fourth quarter of fiscal 2014 totaled $113.7 million compared to $113.3 million for the same period last year. The prior-year period included accretive revenue from a large fixed-price contract that came to an end in early 2014 and offset organic revenue growth from the Company’s operations in Australia. Human Services Segment operating income for the fourth quarter of 2014 decreased to $9.0 million (7.9% operating margin) compared to $11.9 million (10.5% operating margin) for the same period last year. Operating margins in the fourth quarter of 2014 were tempered due to the completion of the fixed price contract, a contract change in the U.K. Work Programme, start-up in Australia for the 18 new site locations and higher expenses in preparation for the Job Services Australia (JSA) rebid.
 
In fiscal year 2013, the Human Services Segment benefitted from a terminated contract that contributed revenue of $16.0 million and pre-tax income of $10.9 million.
 
Human Services Segment revenue for fiscal year 2014 totaled $450.3 million and, excluding the $16.0 million in revenue from the terminated contract, was comparable to same period last year. Fiscal 2014 revenue was tempered by currency fluctuations and the completion of a large, accretive fixed-price contract that came to an end in early 2014, both of which offset organic revenue growth from operations outside the U.S. For the full fiscal year, operating income from the Human Services Segment totaled $50.5 million (11.2% operating margin).
 
Backlog, Sales and Pipeline
 
Backlog reached a record level of $3.8 billion at September 30, 2014. This compares to $3.4 billion at September 30, 2013.
 
Year-to-date signed contract awards at September 30, 2014 totaled $2.0 billion compared to $1.9 billion reported for the same period last year. New contracts pending (awarded but unsigned) totaled $326.9 million at September 30, 2014 and did not include the new health and disability assessments contract that was awarded subsequent to September 30, 2014.
 
 
 
 
 
Sales pipeline at September 30, 2014 was $3.5 billion (consisting of $397 million in proposals pending, $156 million in proposals in preparation, and $2.9 billion in opportunities tracking). The pipeline reflects opportunities in both segments and across multiple geographies.
 
Balance Sheet and Cash Flows
 
Cash and cash equivalents at September 30, 2014 totaled $158.1 million, of which approximately $95 million is held outside of the U.S. For the fourth quarter of fiscal 2014, cash provided by operating activities totaled $48.5 million, with free cash flow of $28.9 million. For fiscal year 2014, cash provided by operating activities totaled $213.6 million, with free cash flow of $166.5 million. For the fourth quarter of fiscal 2014, Days Sales Outstanding (DSO) were 61 days, which is below the Company’s previously stated range of 65 to 80 days.
 
On August 29, 2014, MAXIMUS paid a quarterly cash dividend of $0.045 per share. On October 8, 2014, the Company announced a $0.045 per share cash dividend, payable on November 28, 2014 to shareholders of record on November 14, 2014.
 
During the fourth quarter of fiscal 2014, MAXIMUS repurchased 1,265,484 shares of the Company’s common stock for $52.2 million (a weighted average price of $41.24). For the full fiscal year, MAXIMUS repurchased 2,672,151 shares for $113.1 million (a weighted average price of $42.34). At September 30, 2014, the Company had $135.2 million available for future repurchases under its Board-authorized share repurchase program. Subsequent to September 30, 2014 and through October 28, 2014, the Company repurchased another 753,010 shares of stock for approximately $30.6 million (a weighted average price of $40.66).
 
Outlook
 
MAXIMUS established its fiscal year 2015 revenue and earnings guidance on October 28, 2014. The Company expects fiscal year 2015 revenue to range between $1.9 billion and $2.0 billion and expects diluted earnings per share to range between $2.25 and $2.40. This guidance does not include any possible mergers and acquisition activity or any significant legal expenses or recoveries.
 
Montoni continued, “The horizon for fiscal 2015 and beyond is bright, with several large, new contracts that will serve as the underpinnings for growth over the next few years as they ramp into their full run-rate. For fiscal 2015, MAXIMUS is forecasting top-line growth in the range of 12% to 18% and we estimate that approximately 90% of our forecasted 2015 revenue, based upon the midpoint of our revenue guidance range, is already in the form of backlog or option periods.”
 
Website Presentation, Conference Call and Webcast Information
 
MAXIMUS will host a conference call this morning, November 13, 2014, at 9:00 a.m. (ET). The call is open to the public and can be accessed under the Investor Relations page of the Company’s website at http://investor.maximus.com or by calling:
 
877.407.8289 (Domestic)/201.689.8341 (International)
 
For those unable to listen to the live call, a replay will be available through November 28, 2014. Callers can access the replay by calling:
 
877.660.6853 (Domestic)/201.612.7415 (International)
Replay conference ID number: 13593178
 
About MAXIMUS
 
MAXIMUS is a leading operator of government health and human services programs in the United States, United Kingdom, Canada, Australia and Saudi Arabia. The Company delivers business process services to improve the cost effectiveness, efficiency and quality of government-sponsored benefit programs, such as the Affordable Care Act, Medicaid, Medicare, Children's Health Insurance Program (CHIP), Health Insurance BC (British Columbia), as well as welfare-to-work and child support programs around the globe. The Company's primary customer base includes federal, provincial, state, county and municipal governments. Operating under its founding mission of Helping Government Serve the People®, MAXIMUS has more than 13,000 employees worldwide. For more information, visit www.maximus.com.
 
Non-GAAP Measures
 
This release refers to non-GAAP financial measures, including organic growth, free cash flow and adjusted diluted earnings per share.
 
In order to calculate organic growth, we compare current year revenue to pro forma prior-year revenue, including Health Management Limited. We believe that organic growth provides a useful basis for assessing the performance of the business excluding the effects of acquisitions.
 
We have provided a reconciliation of free cash flow to cash provided by operating activities. We believe that free cash flow is a useful basis for investors to compare our performance across periods or against our competitors. Free cash flow shows the effects of the Company’s operations and routine capital expenditure and excludes the cash flow effects of acquisitions, share repurchases, dividend payments and other financing transactions.
 
We have provided a reconciliation to adjusted diluted earnings per share. We believe that this measure is a useful basis for assessing the Company’s performance excluding the effects of a contract termination in fiscal year 2013.
 
The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operating activities, diluted earnings per share, revenue growth or net income as measures of performance. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.
 
Statements that are not historical facts, including statements about the Company's confidence and strategies and the Company's expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand or acceptance of the Company's products are forward-looking statements that involve risks and uncertainties. These uncertainties could cause the Company's actual results to differ materially from those indicated by such forward-looking statements and include reliance on government clients; risks associated with government contracting; risks involved in managing government projects; legislative changes and political developments; opposition from government unions; challenges resulting from growth; adverse publicity; and legal, economic, and other risks detailed in Exhibit 99.1 to the Company's most recent Annual Report filed with the Securities and Exchange Commission, found on www.maximus.com.
 
 
 
 
 
 
MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except per share data)
(Unaudited)
 
     
 
   
Three Months
  
Year
   
Ended September 30,
  
Ended September 30,
   
 
  
2013
  
 
  
 
Revenue
   $ 435,406     $ 384,339     $ 1,700,912     $ 1,331,279  
Cost of revenue
     322,474       266,840       1,248,789       945,246  
Gross profit
     112,932       117,499       452,123       386,033  
Selling, general and administrative expenses
     61,124       60,476       226,815       200,878  
Operating income
     51,808       57,023       225,308       185,155  
Interest and other income, net
     758       315       2,061       3,867  
Income before income taxes
     52,566       57,338       227,369       189,022  
Provision for income taxes
     16,414       21,918       81,973       71,673  
Net income
     36,152       35,420       145,396       117,349  
Loss/(Income) attributable to non-controlling interests
     84       206       44       (618 )
Net income attributable to MAXIMUS
   $ 36,236     $ 35,626     $ 145,440     $ 116,731  
                           
Basic earnings per share
   $ 0.54     $ 0.52     $ 2.15     $ 1.71  
                           
Diluted earnings per share
   $ 0.53     $ 0.51     $ 2.11     $ 1.67  
                           
Dividends per share
   $ 0.045     $ 0.045     $ 0.18     $ 0.18  
                           
Weighted average shares outstanding:
                          
Basic
     66,784       68,157       67,680       68,165  
Diluted
     68,233       69,950       69,087       69,893  
                                 
 
 
 
 
 
MAXIMUS, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
   
         
         
   
 
   
 
  
2013
ASSETS
   (Unaudited)        
Current assets:
                
Cash and cash equivalents
   $ 158,112     $ 125,617  
Accounts receivable—billed and billable, net
     263,011       264,300  
Accounts receivable—unbilled
     26,556       28,656  
Deferred income taxes
     28,108       26,443  
Prepaid expenses and other current assets
     56,673       44,583  
Total current assets
     532,460       489,599  
                 
Property and equipment, net
     80,246       77,710  
Capitalized software, net
     39,734       40,456  
Goodwill
     170,626       171,867  
Intangible assets, net
     39,239       42,039  
Deferred contract costs, net
     12,046       14,318  
Deferred compensation plan assets
     17,126       10,314  
Other assets
     9,519       11,675  
Total assets
   $ 900,996     $ 857,978  
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY
                
Current liabilities:
                
Accounts payable and accrued liabilities
   $ 103,181     $ 109,020  
Accrued compensation and benefits
     94,137       83,280  
Deferred revenue
     55,878       53,137  
Income taxes payable
     4,693       8,327  
Other liabilities
     7,432       8,276  
Total current liabilities
     265,321       262,040  
Deferred revenue, less current portion
     32,257       32,953  
Deferred income taxes
     21,383       16,359  
Deferred compensation plan liabilities, less current portion
     18,768       13,953  
Other liabilities
     7,082       2,898  
Total liabilities
     344,811       328,203  
                 
Total equity
     556,185       529,775  
Total liabilities and equity
   $ 900,996     $ 857,978  
                 
 
 
 
 
 
 
MAXIMUS, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands; Unaudited)
 
   
Three Months
  
Year
   
Ended September 30,
  
Ended September 30,
   
2014
  
2013
  
2014
  
2013
Cash flows from operating activities:
                
Net income
  
$
36,152
    
$
35,420
    
$
145,396
    
$
117,349
  
Adjustments to reconcile net income to net cash provided by operating activities:
                
Depreciation and amortization
    
12,371
      
10,053
      
48,668
      
35,816
  
Deferred income taxes
    
3,475
      
(634
)
    
2,898
      
2,396
  
Stock compensation expense
    
4,469
      
3,847
      
17,278
      
14,555
  
Changes in assets and liabilities, net of effects of business combinations and divestitures:
                
Accounts receivable — billed
    
1,218
      
(43,020
)
    
(144
)
    
(87,999
)
Accounts receivable — unbilled
    
(1,224
)
    
(3,984
)
    
2,056
      
(14,998
)
Prepaid expenses and other current assets
    
(1,197
)
    
30
      
(2,540
)
    
(2,492
)
Deferred contract costs
    
1,698
      
(2,622
)
    
2,254
      
(5,073
)
Accounts payable
    
2,758
      
15,132
      
(2,928
)
    
31,453
  
Accrued compensation and benefits
    
9,767
      
14,367
      
12,277
      
21,308
  
Deferred revenue
    
2,753
      
9,244
      
2,841
      
6,304
  
Income taxes
    
(17,136
)
    
(3,955
)
    
(10,974
)
    
2,034
  
Other assets and liabilities
    
(6,654
)
    
(1,515
)
    
(3,482
)
    
285
  
Cash provided by operating activities
    
48,450
      
32,363
      
213,600
      
120,938
  
                 
Cash flows from investing activities:
                
Acquisition of business, net of cash acquired
    
—
      
(71,435
)
    
(2,670
)
    
(71,435
)
Proceeds from settlement of final PSI price
    
—
      
—
      
—
      
3,380
  
Purchases of property and equipment
    
(17,873
)
    
(18,711
)
    
(36,262
)
    
(43,580
)
Capitalized software costs
    
(1,709
)
    
(4,944
)
    
(10,886
)
    
(18,596
)
Proceeds from note receivable
    
79
      
113
      
429
      
398
  
Cash used in investing activities
    
(19,503
)
    
(94,977
)
    
(49,389
)
    
(129,833
)
                 
Cash flows from financing activities:
                
Cash dividends paid
    
(3,006
)
    
(3,070
)
    
(12,187
)
    
(12,272
)
Repurchases of common stock
    
(51,787
)
    
(5,473
)
    
(111,141
)
    
(33,287
)
Stock compensation tax benefit
    
6,740
      
5,889
      
9,665
      
10,569
  
Tax withholding related to RSU vesting
    
—
      
—
      
(14,681
)
    
(8,868
)
Stock option exercises
    
217
      
328
      
1,362
      
2,168
  
Issuance of debt
    
—
      
—
      
15,000
      
—
  
Repayment of debt
    
(40
)
    
(42
)
    
(15,162
)
    
(172
)
Cash used in financing activities
    
(47,876
)
    
(2,368
)
    
(127,144
)
    
(41,862
)
     
Effect of exchange rate changes on cash and cash equivalents
    
(5,901
)
    
2,688
      
(4,572
)
    
(12,938
)
                 
Net increase/(decrease) in cash and cash equivalents
    
(24,830
)
    
(62,294
)
    
32,495
      
(63,695
)
                 
Cash and cash equivalents, beginning of period
    
182,942
      
187,911
      
125,617
      
189,312
  
                 
Cash and cash equivalents, end of period
  
$
158,112
    
$
125,617
    
$
158,112
    
$
125,617
  
                 
 
 
 
 
 
         
MAXIMUS, Inc.
SEGMENT INFORMATION
(Amounts in thousands)
(Unaudited)
         
   
Three Months Ended September 30,
  
Year Ended September 30,
   
2014
  
% (1)
  
2013
  
% (1)
  
2014
  
% (1)
  
2013
  
% (1)
                                 
Revenue:
                                
Health Services
  
$
321,700
    
100
%
  
$
271,032
    
100
%
  
$
1,250,565
    
100
%
  
$
862,879
    
100
%
Human Services
    
113,706
    
100
%
    
113,307
    
100
%
    
450,347
    
100
%
    
468,400
    
100
%
Total
    
435,406
    
100
%
    
384,339
    
100
%
    
1,700,912
    
100
%
    
1,331,279
    
100
%
                                 
Gross profit:
                                
Health Services
    
84,001
    
26.1
%
    
85,322
    
31.5
%
    
325,559
    
26.0
%
    
248,100
    
28.8
%
Human Services
    
28,931
    
25.4
%
    
32,177
    
28.4
%
    
126,564
    
28.1
%
    
137,933
    
29.4
%
Total
    
112,932
    
25.9
%
    
117,499
    
30.6
%
    
452,123
    
26.6
%
    
386,033
    
29.0
%
                                 
SG&A expense:
                                
Health Services
    
41,201
    
12.8
%
    
39,384
    
14.5
%
    
150,181
    
12.0
%
    
118,266
    
13.7
%
Human Services
    
19,925
    
17.5
%
    
20,245
    
17.9
%
    
76,022
    
16.9
%
    
79,842
    
17.0
%
Non-segment, net(2)
    
(4
)
  
NM
      
668
    
NM
      
596
    
NM
      
1,966
    
NM
  
Other
    
2
    
NM
      
179
    
NM
      
16
    
NM
      
804
    
NM
  
Total
    
61,124
    
14.0
%
    
60,476
    
15.7
%
    
226,815
    
13.3
%
    
200,878
    
15.1
%
                                 
Operating income:
                                
Health Services
    
42,800
    
13.3
%
    
45,938
    
16.9
%
    
175,378
    
14.0
%
    
129,834
    
15.0
%
Human Services
    
9,006
    
7.9
%
    
11,932
    
10.5
%
    
50,542
    
11.2
%
    
58,091
    
12.4
%
Non-segment, net(2)
    
4
    
NM
      
(668
)
  
NM
      
(596
)
  
NM
      
(1,966
)
  
NM
  
Other
    
(2
)
  
NM
      
(179
)
  
NM
      
(16
)
  
NM
      
(804
)
  
NM
  
Total
  
$
51,808
    
11.9
%
  
$
57,023
    
14.8
%
  
$
225,308
    
13.2
%
  
$
185,155
    
13.9
%
                                                         
 
(1)
  
Percentage of respective segment revenue. Changes not considered meaningful are marked “NM.”
(2)
  
Legal, settlement, and acquisition-related expenses and recoveries
     
 
 
 
 
 
 
MAXIMUS, Inc.
Non-GAAP Measures
 
ADJUSTED DILUTED EPS
FY 2013
(Unaudited)
 
                 
       
Year
   
Quarter Ended
   Ended
   
Dec. 31,
  
Mar. 31,
  
Jun. 30,
   Sept. 30,   Sept. 30,
    2012   2013   2013   2013   2013
                                         
Diluted EPS - GAAP basis
   $ 0.31     $ 0.45     $ 0.40     $ 0.51     $ 1.67  
                             
Adjustment for terminated contract
     –       (0.09 )     –       –       (0.09 )
                             
Adjusted Diluted EPS
   $ 0.31     $ 0.36     $ 0.40     $ 0.51     $ 1.58  
                                         
 
 
FREE CASH FLOW
(Dollars in thousands; Unaudited)
 
   
Three Months
  
Year
   
Ended September 30,
  
Ended September 30,
   
2014
  
2013
  
2014
  
2013
                 
Cash provided by operating activities
  
$
48,450
    
$
32,363
    
$
213,600
    
$
120,938
  
Purchases of property and equipment
    
(17,873
)
    
(18,711
)
    
(36,262
)
    
(43,580
)
Capitalized software costs
    
(1,709
)
    
(4,944
)
    
(10,886
)
    
(18,596
)
Free cash flow
  
$
28,868
    
$
8,708
    
$
166,452
    
$
58,762
  
                 
 
CONTACT:
MAXIMUS
Lisa Miles, 703-251-8637
lisamiles@maximus.com